Company Profiles

driven by the PitchBook Platform

Xentech

Xentech
2006 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Seed LATEST DEAL TYPE
$801k LATEST DEAL AMOUNT
$801k TOTAL AMOUNT RAISED
Description

Developer of therapeutics for cancer treatment. The company is focused on therapeutic development and offers preclinical services to evaluate the anti-cancer potential of drug candidates.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Drug Discovery
Primary Office
4, rue Pierre Fontaine
91000 √Čvry
France

+33 (0)1 60 87 89 80
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xentech’s full profile, request a free trial.

Xentech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 31-Oct-2008 $801k $801k Completed Clinical Trials - General
1. Accelerator/Incubator 01-Jan-2006 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Xentech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aurinvest Venture Capital Minority 000 0000 000000 0
IncubAlliance Accelerator/Incubator Minority 000 0000 000000 0

You’re viewing 2 of 2 investors.

Xentech Executive Team (7)

Name Title Board
Seat
Contact
Info
Jean-Gabriel Judde Ph.D Co-Founder, Co-Owner, President & Chief Scientific Officer
Pascal Leuraud Ph.D Chief Operating Officer & Co-Founder
Delphine Nicolle Ph.D Study Director
Marie Tavernier Study Director
Myriam Lassalle Study Director in Preclinical Oncology
You’re viewing 5 of 7 executives. Get the full list »